Ephion Health Platform

The platform to develop and deploy digital clinical measures for patient mobility Ephion health is a Spin-Off from Eurecat

Ephion Health Platform

The platform to develop and deploy digital clinical measures for patient mobility Ephion health is a Spin-Off from Eurecat
Institution: Eurecat
Research group: eHealth Eurecat
Principal investigator: Felip Miralles

The Problem

Duchenne Muscular Dystrophy is a genetic disorder characterized by the progressive loss of muscle. Most children with DMD use a wheelchair by their early teens. Heart and breathing problems also begin in the teen years and lead to serious, life threatening complications. Currently, there is much interest in Real-World Assessment of Physical Function and Mobility as endpoints to clinical indications such as the above mentioned Duchenne Muscular Dystrophy, both for monitoring of patients and developing new treatments. Most current solutions are centered on proprietary hardware relying on this single proprietary wearable as the only source of health data. The lack of data analytics, an AI-driven platform, and the use of single sensors hinders the combination and integration of key parameters. Current systems do not allow to obtain a holistic view of the patient’s health, and at the same time, the data they provide is difficult to integrate into existing Electronic Health Record (EHR) systems.
EPHION focuses on the development and deployment of ethical and trustworthy AI to analyse the integration of heterogeneous data provided by different commercially available sensors in order to obtain a holistic view of the patient’s health, and identify new composite scores that can predict medical outcomes.

The Solution

The Solution

EPHION focuses on the development and deployment of ethical and trustworthy AI to analyse the integration of heterogeneous data provided by different commercially available sensors in order to obtain a holistic view of the patient’s health, and identify new composite scores that can predict medical outcomes.

Purpose

EPHION aims for a leading position globally in this technology thanks to its advantage as first to market in specific diseases. – Hospitals and Rehabilitation Centres: A simple and flexible tool capable of providing the requested set of mobility outcomes or multivariable score to monitor patients.
Time to market: 1 year
Looking for: Contacting with Hospitals and Rehabilitation Centres, CROs & Pharmaceutical companies and Health Insurance companies
Technology: Artificial Intelligence
Area: Any mobility-affecting disease
TRL: 7